SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

Uric acid is the end product of purine metabolism in humans and great apes, which have lost hepatic uricase activity, leading to uniquely high serum uric acid concentrations (200-500 μM) compared with other mammals (3-120 μM). About 70% of daily urate disposal occurs via the kidneys, and in 5-25% of...

Full description

Saved in:
Bibliographic Details
Published inNature genetics Vol. 40; no. 4; pp. 437 - 442
Main Authors Wright, Alan F, Vitart, Veronique, Rudan, Igor, Hayward, Caroline, Gray, Nicola K, Floyd, James, Palmer, Colin NA, Knott, Sara A, Kolcic, Ivana, Polasek, Ozren, Graessler, Juergen, Wilson, James F, Marinaki, Anthony, Riches, Philip L, Shu, Xinhua, Janicijevic, Branka, Smolej-Narancic, Nina, Gorgoni, Barbara, Morgan, Joanne, Campbell, Susan, Biloglav, Zrinka, Barac-Lauc, Lovorka, Pericic, Marijana, Klaric, Irena Martinovic, Zgaga, Lina, Skaric-Juric, Tatjana, Wild, Sarah H, Richardson, William A, Hohenstein, Peter, Kimber, Charley H, Tenesa, Albert, Donnelly, Louise A, Fairbanks, Lynette D, Aringer, Martin, McKeigue, Paul M, Ralston, Stuart H, Morris, Andrew D, Rudan, Pavao, Hastie, Nicholas D, Campbell, Harry
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.04.2008
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Uric acid is the end product of purine metabolism in humans and great apes, which have lost hepatic uricase activity, leading to uniquely high serum uric acid concentrations (200-500 μM) compared with other mammals (3-120 μM). About 70% of daily urate disposal occurs via the kidneys, and in 5-25% of the human population, impaired renal excretion leads to hyperuricemia. About 10% of people with hyperuricemia develop gout, an inflammatory arthritis that results from deposition of monosodium urate crystals in the joint. We have identified genetic variants within a transporter gene, SLC2A9, that explain 1.7-5.3% of the variance in serum uric acid concentrations, following a genome-wide association scan in a Croatian population sample. SLC2A9 variants were also associated with low fractional excretion of uric acid and/or gout in UK, Croatian and German population samples. SLC2A9 is a known fructose transporter, and we now show that it has strong uric acid transport activity in Xenopus laevis oocytes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1061-4036
1546-1718
DOI:10.1038/ng.106